🔎 Trials Near Me

Domov › Rakovina prsníka › Iowa

Klinické štúdie Rakovina prsníka v štáte Iowa

22 štúdií pre Rakovina prsníka hľadá účastníkov v zariadeniach v štáte Iowa.

Mestá v štáte Iowa

Oficiálny text štúdie (anglicky)

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

  • Mary Greeley Medical Center, Ames
  • McFarland Clinic - Ames, Ames
  • UI Health Care Mission Cancer and Blood - Ankeny Clinic, Ankeny
  • a 12 ďalších
Prebieha náborObservačná štúdiaVítaní zdravých dobrovoľníkov
Vek 40 až 75 · Všetky pohlavia · Aktualizované 2. 10. 2026 · NCT05334069

A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer

  • Accellacare of McFarland, Ames
Prebieha náborFáza 2
Vek 18 a viac · Všetky pohlavia · Aktualizované 1. 10. 2026 · NCT07102381

Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread

  • University of Iowa Hospitals and Clinics, Iowa City
Prebieha náborFáza 1/2
Vek 18 a viac · Všetky pohlavia · Aktualizované 30. 9. 2026 · NCT06324357

A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors

  • Local Institution - 0065, Iowa City
Prebieha náborFáza 1/2
Vek 18 a viac · Všetky pohlavia · Aktualizované 23. 9. 2026 · NCT06618287

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

  • University of Iowa, Iowa City
Prebieha náborFáza 3
Vek 18 a viac · Všetky pohlavia · Aktualizované 22. 9. 2026 · NCT07174336

A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence

  • Mission Cancer and Blood, Des Moines
Prebieha náborFáza 3
Vek 18 a viac · Všetky pohlavia · Aktualizované 15. 9. 2026 · NCT06492616

BGB-21447 (Bcl-2 Inhibitor) Combinations for Adults With Hormone-Receptor Positive (HR+)/Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Metastatic Breast Cancer

  • University of Iowa Hospitals and Clinics, Iowa City
Prebieha náborFáza 1
Vek 18 a viac · Všetky pohlavia · Aktualizované 14. 9. 2026 · NCT06756932

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

  • Mary Greeley Medical Center, Ames
  • McFarland Clinic - Ames, Ames
  • UI Health Care Mission Cancer and Blood - Ankeny Clinic, Ankeny
  • a 17 ďalších
Prebieha náborFáza 3
Vek 18 až 60 · Ženy · Aktualizované 2. 9. 2026 · NCT05879926

A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors

  • University of Iowa, Iowa City
Prebieha náborFáza 1
Vek 18 a viac · Všetky pohlavia · Aktualizované 28. 8. 2026 · NCT07029399

Exercise Oncology Clinic Pilot Feasibility Trial

  • University of Iowa Health Care, Iowa City
Prebieha nábor
Vek 18 a viac · Všetky pohlavia · Aktualizované 14. 8. 2026 · NCT07765927

Breast Cancer PSMA PET

  • University of Iowa Healthcare, Iowa City
Prebieha náborSkorá fáza 1
Vek 18 až 90 · Ženy · Aktualizované 6. 8. 2026 · NCT06586047

E-Mindfulness Approaches for Living After Breast Cancer

  • UI Health Care Mission Cancer and Blood - Ankeny Clinic, Ankeny
  • University of Iowa Healthcare Cancer Services Quad Cities, Bettendorf
  • Saint Anthony Regional Hospital, Carroll
  • a 10 ďalších
Prebieha náborFáza 3
Vek 18 až 50 · Všetky pohlavia · Aktualizované 4. 8. 2026 · NCT06748222

First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors

  • University of Iowa, Iowa City
Prebieha náborFáza 1/2
Vek 18 a viac · Všetky pohlavia · Aktualizované 7. 7. 2026 · NCT05768139

Abemaciclib Dose Escalation to Maintain Intensity (ADE-MI)

  • Iowa Holden Comprehensive Cancer Center, Iowa City
Prebieha náborFáza 4
Vek 18 a viac · Všetky pohlavia · Aktualizované 7. 7. 2026 · NCT06169371

Integrated Cancer Repository for Cancer Research

  • Methodist Jennie Edmundson Hospital, Council Bluffs
  • Covenant Medical Center, Inc, Waterloo
Prebieha náborObservačná štúdiaVítaní zdravých dobrovoľníkov
Vek 19 až 110 · Všetky pohlavia · Aktualizované 29. 6. 2026 · NCT02012699

Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors

  • University of Iowa Health Care, Iowa City
Prebieha náborFáza 1
Vek 18 a viac · Všetky pohlavia · Aktualizované 11. 6. 2026 · NCT05283330

De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)

  • Mary Greeley Medical Center, Ames
  • McFarland Clinic - Ames, Ames
  • UI Health Care Mission Cancer and Blood - Ankeny Clinic, Ankeny
  • a 11 ďalších
Prebieha náborFáza 3
Vek 50 až 70 · Všetky pohlavia · Aktualizované 23. 4. 2026 · NCT04852887

Quantitative MRI Assessment of Breast Cancer Therapy Response

  • University of Iowa, Iowa City
Prebieha náborObservačná štúdia
Vek 18 a viac · Všetky pohlavia · Aktualizované 17. 4. 2026 · NCT05704062

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

  • UI Health Care Mission Cancer and Blood - Ankeny Clinic, Ankeny
  • University of Iowa Healthcare Cancer Services Quad Cities, Bettendorf
  • Physicians' Clinic of Iowa PC, Cedar Rapids
  • a 10 ďalších
Prebieha náborObservačná štúdia
Vek 18 a viac · Všetky pohlavia · Aktualizované 17. 3. 2026 · NCT06418204

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  • Massive Bio SYNERGY-AI site, Iowa City
Prebieha náborObservačná štúdia
Všetky vekové kategórie · Všetky pohlavia · Aktualizované 28. 10. 2025 · NCT03452774

S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity

  • Medical Oncology and Hematology Associates-West Des Moines, Clive
  • Mercy Cancer Center-West Lakes, Clive
  • Mercy Medical Center - Des Moines, Des Moines
  • a 2 ďalších
Prebieha náborFáza 3
Vek 18 a viac · Všetky pohlavia · Aktualizované 8. 10. 2025 · NCT03418961

Z ClinicalTrials.gov, dáta načítané 6. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.